| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |